The results showed that the mechanism by which AME improves insulin resistance in HepG2 cells may be related to the PI3K-Akt signaling pathway, which promotes glucose oxygenolysis and glycogen synthesis and inhibits gluconeogenesis and the level of inflammatory cytokines. Here, AKT1 is linked to Insulin resistance.